1 results match your criteria: "Traditional Tibetan Medical Research and Study Institute of Regional Traditional Tibetan Medical Hospital[Affiliation]"
Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer.
Artif Cells Nanomed Biotechnol
December 2019
Traditional Tibetan Medical Research and Study Institute of Regional Traditional Tibetan Medical Hospital, Lhasa , China.
Article Synopsis
- Lung cancer is caused by uncontrolled growth of cells in the lungs, which can spread to other parts of the body through metastasis.
- Researchers developed a new treatment using DQA-modified paclitaxel and ligustrazine micelles to target and destroy vasculogenic mimicry (VM) channels, thereby inhibiting tumor metastasis.
- The study showed that these micelles effectively accumulated in tumor sites, demonstrated strong anti-cancer effects on A549 cells, and had minimal toxicity, suggesting a promising new strategy for treating non-small cell lung cancer (NSCLC).